Medicamen Biotech Share Price Today - Live Research Rating for Medicamen Biotech on Equentis

Home

Stocks Screener

Medicamen Biotech Share Price

Medicamen Biotech (INR)522.6-27.4 (-5%)

Exchange ScripsBSE531146NSEMEDICAMEQISININE646B01010

Stock Performance

Fundamentals

Technicals

Shareholding Patterns

Financials

Similar Stocks

Trendline of performance -

Medicamen Biotech Performance

Market performance

Open price553

High558.7

Volumes22890

Prev Close522.6

Low513.6

Closing date2024-12-20

Historical performance

1 Year High630.00

3 Year High1225.00

5 Year High1225.00

1 Year Low355.45

3 Year Low355.45

5 Year Low355.45

Medicamen Biotech Fundamentals

Company Valuation

Market Cap (₹Cr)

663

Face Value (₹)

P/E Ratio

69.99

Dividend Yield

0.02 %

Medicamen Biotech Investment Returns

1 Year

-6.1%

3 Years

-38.2%

5 Years

N/A

10 Years

N/A

Medicamen Biotech Technicals

Indicators	Value	Signal
5-DMA	554.73	Bearish
10-DMA	569.2	Bearish
20-DMA	527.93	Bearish
50-DMA	515.33	Bullish
100-DMA	483.61	Bullish
200-DMA	475.07	Bullish

Shareholding Pattern

Field	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Promoters	1	1	1	2	2
Foreign Investors	---	---	---	---	---
Domestic Investors	1	1	1	2	2
Public Investors	10791	10651	10638	10250	9417
Government	---	---	---	---	---

Medicamen Biotech Financials

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Other Income	23	25	17	8
Operating Profit	258	268	258	204
Interest	57	34	19	15
Depreciation	71	64	58	25
Profit Before Tax	131	170	181	164
Consolidated Net Profit	95	147	149	121
Adjusted EPS	7	12	12	10

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	127	127	122	122
Total Reserves	1943	1782	1343	1207
Minority Interest	---	---	---	---
Total Non-Current Liabilities	5	7	60	78
Total Liabilities	2920	2766	2252	1940
Capital Work in Progress	---	---	---	---
Total Assets	2920	2766	2252	1940

Cash Flow

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Cash Flow from Operating Activities	-67	-63	41	128
Cash Flow from Investing Activities	-56	-59	-85	-178
Cash Flow from Financing Activitie	63	291	43	58
Net Cash Inflow / Outflow	-60	170	-1	8

Negative

Neutral

Positive

The stock has a PE ratio of 69.99.
3Y Stock Price CAGR of the stock is -14.7.
The stock has a beta of 1.4.
In the last financial year, the company had an EBITDA of ₹258 Million.
The company generated revenue of ₹1793 Million in the previous financial year.

Medicamen Biotech

522.6-27.4 (-5%)

Investment Amount: ₹ 55590

Current Value: ₹ 52260

Performance: -6%

P/L: ₹ -3330

Top Gainers

Symbol	Change%
KOTHARIPRO	205.06(20%)
LAGNAM	132.13(18%)
GICRE	501(13%)
HISARMETAL	217.94(11%)
DIAMONDYD	1081.55(11%)

Top Losers

Symbol	Change%
UNIINFO	37.61(-13%)
BALAJITELE	79.8(-10%)
SIEMENS	6868.9(-10%)
MOBIKWIK	487.95(-10%)
TORNTPOWER	1479.2(-9%)
BAJAJHCARE	533.9(-9%)
SARLAPOLY	116.77(-9%)
SURYALAXMI	87.14(-9%)